title: Proton pump inhibitors impact on post-endoscopic retrograde cholangiopancreatography pancreatitis.
authors: Department of Internal Medicine Akron General Medical Center Cleveland Clinic, Akron, OH mohamed.abdelfatah@akrongeneral.org Department of Internal Medicine Akron General Medical Center Cleveland Clinic Akron, OH Department Gastroenterology and Hepatology University Hospitals Case Medical Center Cleveland, OH Departments of Pharmacy Practice and Internal Medicine, Northeast Ohio Medical University Rootstown, OH Department Gastroenterology and Hepatology Akron General Medical Center Cleveland Clinic Akron, OH Department Gastroenterology and Hepatology East Carolina University Greenville, NC.
authors: Mohamed M
authors: MM
authors: Abdelfatah
authors: Rabih
authors: R
authors: Nayfe
authors: Maysaa
authors: M
authors: El Zoghbi
authors: Patrick
authors: P
authors: Gallegos
authors: Martin
authors: M
authors: Shill
authors: Hossam
authors: H
authors: Kandil
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000209:etiology / Q000517:prevention & control*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D054328:Proton Pump Inhibitors